a public good project by the
Synthesis
Company
of California

© 2026

Tao Qing | doi.page

0 works0 citations0 h-index

Tao Qing

Jiangsu University(CN)Donghua University(CN)Anhui Medical University(CN)Sichuan University(CN)Jiangxi Science and Technology Normal University(CN)West China Hospital of Sichuan University(CN)Affiliated Hospital of Jiangsu University(CN)Second Hospital of Anhui Medical University(CN)

Publications by Year

Research Areas

Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Cannabis and Cannabinoid Research, Cancer-related molecular mechanisms research, Bioinformatics and Genomic Networks

Most-Cited Works

→ Comparison of RNA-seq and microarray-based models for clinical endpoint prediction(2015)426 cited
→ A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages(2014)425 cited
→ Levels, Metabolism, and Pharmacological Activity of Anandamide in CB₁ Cannabinoid Receptor Knockout Mice(2000)394 cited
→ Next-generation sequencing in the clinic: Promises and challenges(2012)356 cited
→ A Comprehensive Mouse Transcriptomic BodyMap across 17 Tissues by RNA-seq(2017)207 cited
→ Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor(2000)204 cited

→ Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system(1999)

147 cited

→ Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice(2005)134 cited

→ Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden(2020)126 cited

→ In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects(2013)125 cited